BNP Paribas Financial Markets
CBST

BNP Paribas Financial Markets’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BNP Paribas Financial Markets’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-72,825
Closed -$7.33M – 3689
2014
Q4 		$7.33M Sell
72,825
-20,245
-22% -$1.57M 0.03% 523
2014
Q3 		$6.17M Sell
93,070
-10,437
-10% -$686K 0.01% 661
2014
Q2 		$7.23M Sell
103,507
-8,475,120
-99% -$576M 0.01% 531
2014
Q1 		$2.03B Buy
8,578,627
+8,525,068
+15,917% +$636M 1.58% 16
2013
Q4 		$1.95B Sell
53,559
-9,406,803
-99% -$609M 1.42% 13
2013
Q3 		$1.37B Sell
9,460,362
-7,814,638
-45% -$472M 0.99% 28
2013
Q2 		$3.03B Buy
+17,275,000
New +$849M 2.14% 7

BNP Paribas Financial Markets's CBST Position: Q1 2015 in Review

BNP Paribas Financial Markets sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 72,825 shares — an estimated $7.33M sold.

BNP Paribas Financial Markets first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $3.03B in Q2 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BNP Paribas Financial Markets reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 72,825 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $7.33M.
  • BNP Paribas Financial Markets first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BNP Paribas Financial Markets's CUBIST PHARMACEUTICALS INC position peaked at $3.03B in Q2 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2015, filed 15 May 2015.